{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T14:19:20Z","timestamp":1761920360130},"reference-count":40,"publisher":"Baishideng Publishing Group Inc.","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["WJH"],"published-print":{"date-parts":[[2011]]},"DOI":"10.4254\/wjh.v3.i6.157","type":"journal-article","created":{"date-parts":[[2017,11,2]],"date-time":"2017-11-02T08:00:17Z","timestamp":1509609617000},"page":"157","source":"Crossref","is-referenced-by-count":13,"title":["MELD score, insulin-like growth factor 1 and cytokines on bone density in end-stage liver disease"],"prefix":"10.4254","volume":"3","author":[{"given":"Rebecca","family":"Mitchell","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jill","family":"McDermid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mang M","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Constance L","family":"Chik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2060","reference":[{"key":"ref1","doi-asserted-by":"crossref","unstructured":"Diamond TH, Stiel D, Lunzer M, McDowall D, Eckstein RP, Posen S. Hepatic osteodystrophy. Static and dynamic bone histomorphometry and serum bone Gla-protein in 80 patients with chronic liver disease. Gastroenterology 1989;96:213-221.","DOI":"10.1016\/0016-5085(89)90783-X"},{"key":"ref2","doi-asserted-by":"crossref","unstructured":"Compston JE. Hepatic osteodystrophy: vitamin D metabolism in patients with liver disease. Gut 1986;27:1073-1090.","DOI":"10.1136\/gut.27.9.1073"},{"key":"ref3","doi-asserted-by":"crossref","unstructured":"Matloff DS, Kaplan MM, Neer RM, Goldberg MJ, Bitman W, Wolfe HJ. Osteoporosis in primary biliary cirrhosis: effects of 25-hydroxyvitamin D3 treatment. Gastroenterology 1982;83:97-102.","DOI":"10.1016\/S0016-5085(82)80291-6"},{"key":"ref4","doi-asserted-by":"crossref","unstructured":"Hodgson SF, Dickson ER, Wahner HW, Johnson KA, Mann KG, Riggs BL. Bone loss and reduced osteoblast function in primary biliary cirrhosis. Ann Intern Med 1985;103:855-860.","DOI":"10.7326\/0003-4819-103-6-855"},{"key":"ref5","doi-asserted-by":"crossref","unstructured":"Bikle DD, Genant HK, Cann C, Recker RR, Halloran BP, Strewler GJ. Bone disease in alcohol abuse. Ann Intern Med 1985;103:42-48.","DOI":"10.7326\/0003-4819-103-1-42"},{"key":"ref6","unstructured":"Conte D, Caraceni MP, Duriez J, Mandelli C, Corghi E, Cesana M, Ortolani S, Bianchi PA. Bone involvement in primary hemochromatosis and alcoholic cirrhosis. Am J Gastroenterol 1989;84:1231-1234."},{"key":"ref7","doi-asserted-by":"crossref","unstructured":"Diamond T, Stiel D, Lunzer M, Wilkinson M, Posen S. Ethanol reduces bone formation and may cause osteoporosis. Am J Med 1989;86:282-288.","DOI":"10.1016\/0002-9343(89)90297-0"},{"key":"ref8","doi-asserted-by":"crossref","unstructured":"Gallego-Rojo FJ, Gonzalez-Calvin JL, Mu\u00f1oz-Torres M, Mundi JL, Fernandez-Perez R, Rodrigo-Moreno D. Bone mineral density, serum insulin-like growth factor I, and bone turnover markers in viral cirrhosis. Hepatology 1998;28:695-699.","DOI":"10.1002\/hep.510280315"},{"key":"ref9","doi-asserted-by":"crossref","unstructured":"Gonzalez-Calvin JL, Gallego-Rojo F, Fernandez-Perez R, Casado-Caballero F, Ruiz-Escolano E, Olivares EG. Osteoporosis, mineral metabolism, and serum soluble tumor necrosis factor receptor p55 in viral cirrhosis. J Clin Endocrinol Metab 2004;89:4325-4330.","DOI":"10.1210\/jc.2004-0077"},{"key":"ref10","doi-asserted-by":"crossref","unstructured":"Janssen JA, Burger H, Stolk RP, Grobbee DE, de Jong FH, Lamberts SW, Pols HA. Gender-specific relationship between serum free and total IGF-I and bone mineral density in elderly men and women. Eur J Endocrinol 1998;138:627-632.","DOI":"10.1530\/eje.0.1380627"},{"key":"ref11","doi-asserted-by":"crossref","unstructured":"Barrett-Connor E, Goodman-Gruen D. Gender differences in insulin-like growth factor and bone mineral density association in old age: the Rancho Bernardo Study. J Bone Miner Res 1998;13:1343-1349.","DOI":"10.1359\/jbmr.1998.13.8.1343"},{"key":"ref12","doi-asserted-by":"crossref","unstructured":"Kurland ES, Rosen CJ, Cosman F, McMahon D, Chan F, Shane E, Lindsay R, Dempster D, Bilezikian JP. Insulin-like growth factor-I in men with idiopathic osteoporosis. J Clin Endocrinol Metab 1997;82:2799-2805.","DOI":"10.1210\/jc.82.9.2799"},{"key":"ref13","doi-asserted-by":"crossref","unstructured":"Ljunghall S, Johansson AG, Burman P, K&auml;mpe O, Lindh E, Karlsson FA. Low plasma levels of insulin-like growth factor 1 (IGF-1) in male patients with idiopathic osteoporosis. J Intern Med 1992;232:59-64.","DOI":"10.1111\/j.1365-2796.1992.tb00550.x"},{"key":"ref14","doi-asserted-by":"crossref","unstructured":"M&oslash;ller S, Becker U. Insulin-like growth factor 1 and growth hormone in chronic liver disease. Dig Dis 1992;10:239-248.","DOI":"10.1159\/000171362"},{"key":"ref15","doi-asserted-by":"crossref","unstructured":"Caregaro L, Alberino F, Amodio P, Merkel C, Angeli P, Plebani M, Bolognesi M, Gatta A. Nutritional and prognostic significance of insulin-like growth factor 1 in patients with liver cirrhosis. Nutrition 1997;13:185-190.","DOI":"10.1016\/S0899-9007(96)00399-1"},{"key":"ref16","doi-asserted-by":"crossref","unstructured":"Ormarsd&oacute;ttir S, Ljunggren O H, Olofsson H, Blum WF, L&ouml;&ouml;f L. Circulating levels of insulin-like growth factors and their binding proteins in patients with chronic liver disease: lack of correlation with bone mineral density. Liver 2001;21:123-128.","DOI":"10.1034\/j.1600-0676.2001.021002123.x"},{"key":"ref17","doi-asserted-by":"crossref","unstructured":"Khoruts A, Stahnke L, McClain CJ, Logan G, Allen JI. Circulating tumor necrosis factor, interleukin-1 and interleukin-6 concentrations in chronic alcoholic patients. Hepatology 1991;13:267-276.","DOI":"10.1002\/hep.1840130211"},{"key":"ref18","unstructured":"Diez Ruiz A, Santos Perez JL, Lopez Martinez G, Gonzalez Calv&iacute;n J, Gil Extremera B, Gutierrez Gea F. Tumour necrosis factor, interleukin-1 and interleukin-6 in alcoholic cirrhosis. Alcohol Alcohol 1993;28:319-323."},{"key":"ref19","doi-asserted-by":"crossref","unstructured":"Zylberberg H, Rimaniol AC, Pol S, Masson A, De Groote D, Berthelot P, Bach JF, Br&eacute;chot C, Zavala F. Soluble tumor necrosis factor receptors in chronic hepatitis C: a correlation with histological fibrosis and activity. J Hepatol 1999;30:185-191.","DOI":"10.1016\/S0168-8278(99)80060-9"},{"key":"ref20","doi-asserted-by":"crossref","unstructured":"Genesca J, Gonzalez A, Segura R, Catalan R, Marti R, Varela E, Cadelina G, Martinez M, Lopez-Talavera JC, Esteban R. Interleukin-6, nitric oxide, and the clinical and hemodynamic alterations of patients with liver cirrhosis. Am J Gastroenterol 1999;94:169-177.","DOI":"10.1111\/j.1572-0241.1999.00790.x"},{"key":"ref21","doi-asserted-by":"crossref","unstructured":"Pfeilschifter J, Chenu C, Bird A, Mundy GR, Roodman GD. Interleukin-1 and tumor necrosis factor stimulate the formation of human osteoclastlike cells in vitro. J Bone Miner Res 1989;4:113-118.","DOI":"10.1002\/jbmr.5650040116"},{"key":"ref22","doi-asserted-by":"crossref","unstructured":"Bertolini DR, Nedwin GE, Bringman TS, Smith DD, Mundy GR. Stimulation of bone resorption and inhibition of bone formation in vitro by human tumour necrosis factors. Nature 1986;319:516-518.","DOI":"10.1038\/319516a0"},{"key":"ref23","doi-asserted-by":"crossref","unstructured":"Manolagas SC, Jilka RL. Bone marrow, cytokines, and bone remodeling. Emerging insights into the pathophysiology of osteoporosis. N Engl J Med 1995;332:305-311.","DOI":"10.1056\/NEJM199502023320506"},{"key":"ref24","doi-asserted-by":"crossref","unstructured":"Manolagas SC. The role of IL-6 type cytokines and their receptors in bone. Ann N Y Acad Sci 1998;840:194-204.","DOI":"10.1111\/j.1749-6632.1998.tb09563.x"},{"key":"ref25","doi-asserted-by":"crossref","unstructured":"Kamath PS, Wiesner RH, Malinchoc M, Kremers W, Therneau TM, Kosberg CL, D&rsquo;Amico G, Dickson ER, Kim WR. A model to predict survival in patients with end-stage liver disease. Hepatology 2001;33:464-470.","DOI":"10.1053\/jhep.2001.22172"},{"key":"ref26","doi-asserted-by":"crossref","unstructured":"Campbell MS, Lichtenstein GR, Rhim AD, Pazianas M, Faust T. Severity of liver disease does not predict osteopenia or low bone mineral density in primary sclerosing cholangitis. Liver Int 2005;25:311-316.","DOI":"10.1111\/j.1478-3231.2005.01075.x"},{"key":"ref27","unstructured":"Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. Report of a WHO Study Group. World Health Organ Tech Rep Ser 1994;843:1-129."},{"key":"ref28","doi-asserted-by":"crossref","unstructured":"Sokhi RP, Anantharaju A, Kondaveeti R, Creech SD, Islam KK, Van Thiel DH. Bone mineral density among cirrhotic patients awaiting liver transplantation. Liver Transpl 2004;10:648-653.","DOI":"10.1002\/lt.20104"},{"key":"ref29","doi-asserted-by":"crossref","unstructured":"Hock JM, Centrella M, Canalis E. Insulin-like growth factor I has independent effects on bone matrix formation and cell replication. Endocrinology 1988;122:254-260.","DOI":"10.1210\/endo-122-1-254"},{"key":"ref30","doi-asserted-by":"crossref","unstructured":"Reed BY, Zerwekh JE, Sakhaee K, Breslau NA, Gottschalk F, Pak CY. Serum IGF 1 is low and correlated with osteoblastic surface in idiopathic osteoporosis. J Bone Miner Res 1995;10:1218-1224.","DOI":"10.1002\/jbmr.5650100812"},{"key":"ref31","doi-asserted-by":"crossref","unstructured":"Jackson JA, Kleerekoper M, Parfitt AM, Rao DS, Villanueva AR, Frame B. Bone histomorphometry in hypogonadal and eugonadal men with spinal osteoporosis. J Clin Endocrinol Metab 1987;65:53-58.","DOI":"10.1210\/jcem-65-1-53"},{"key":"ref32","doi-asserted-by":"crossref","unstructured":"Pignata S, Daniele B, Galati MG, Esposito G, Vallone P, Fiore F, Ricchi P, Pergola M. Oestradiol and testosterone blood levels in patients with viral cirrhosis and hepatocellular carcinoma. Eur J Gastroenterol Hepatol 1997;9:283-286.","DOI":"10.1097\/00042737-199703000-00012"},{"key":"ref33","doi-asserted-by":"crossref","unstructured":"Kaymako\u011flu S, Okten A, Cakalo\u011flu Y, Bozta\u015f G, Be\u015fi\u015fik F, Ta\u015f&ccedil;io\u011flu C, Yal&ccedil;in S. Hypogonadism is not related to the etiology of liver cirrhosis. J Gastroenterol 1995;30:745-750.","DOI":"10.1007\/BF02349641"},{"key":"ref34","unstructured":"Engelberts I, M&ouml;ller A, Schoen GJ, van der Linden CJ, Buurman WA. Evaluation of measurement of human TNF in plasma by ELISA. Lymphokine Cytokine Res 1991;10:69-76."},{"key":"ref35","doi-asserted-by":"crossref","unstructured":"Aukrust P, Liabakk NB, M&uuml;ller F, Lien E, Espevik T, Fr&oslash;land SS. Serum levels of tumor necrosis factor-alpha (TNF alpha) and soluble TNF receptors in human immunodeficiency virus type 1 infection--correlations to clinical, immunologic, and virologic parameters. J Infect Dis 1994;169:420-424.","DOI":"10.1093\/infdis\/169.2.420"},{"key":"ref36","unstructured":"Scheidt-Nave C, Bismar H, Leidig-Bruckner G, Woitge H, Seibel MJ, Ziegler R, Pfeilschifter J. Serum interleukin 6 is a major predictor of bone loss in women specific to the first decade past menopause. J Clin Endocrinol Metab 2001;86:2032-2042."},{"key":"ref37","doi-asserted-by":"crossref","unstructured":"Migita K, Abiru S, Maeda Y, Daikoku M, Ohata K, Nakamura M, Komori A, Yano K, Yatsuhashi H, Eguchi K. Serum levels of interleukin-6 and its soluble receptors in patients with hepatitis C virus infection. Hum Immunol 2006;67:27-32.","DOI":"10.1016\/j.humimm.2006.02.025"},{"key":"ref38","doi-asserted-by":"crossref","unstructured":"Ferrari SL, Garnero P, Emond S, Montgomery H, Humphries SE, Greenspan SL. A functional polymorphic variant in the interleukin-6 gene promoter associated with low bone resorption in postmenopausal women. Arthritis Rheum 2001;44:196-201.","DOI":"10.1002\/1529-0131(200101)44:1<196::AID-ANR26>3.0.CO;2-5"},{"key":"ref39","doi-asserted-by":"crossref","unstructured":"Lorentzon M, Lorentzon R, Nordstr&ouml;m P. Interleukin-6 gene polymorphism is related to bone mineral density during and after puberty in healthy white males: a cross-sectional and longitudinal study. J Bone Miner Res 2000;15:1944-1949.","DOI":"10.1359\/jbmr.2000.15.10.1944"},{"key":"ref40","doi-asserted-by":"crossref","unstructured":"Schulte CM, Dignass AU, Goebell H, R&ouml;her HD, Schulte KM. Genetic factors determine extent of bone loss in inflammatory bowel disease. Gastroenterology 2000;119:909-920.","DOI":"10.1053\/gast.2000.18158"}],"container-title":["World Journal of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.wjgnet.com\/1948-5182\/full\/v3\/i6\/157.htm","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,21]],"date-time":"2020-10-21T00:02:42Z","timestamp":1603238562000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.wjgnet.com\/1948-5182\/full\/v3\/i6\/157.htm"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011]]},"references-count":40,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.4254\/wjh.v3.i6.157","relation":{},"ISSN":["1948-5182"],"issn-type":[{"value":"1948-5182","type":"print"}],"subject":[],"published":{"date-parts":[[2011]]}}}